Shareholders elect three Class I directors and ratify PwC as auditor for FY2022

Bolt Biotherapeutics, Inc.

Frank D. Lee (23,819,385 votes for), Brian O'Callaghan (22,559,100), Mahendra G. Shah (19,746,587) elected to Board.
Ratification of PricewaterhouseCoopers LLP as auditor for fiscal 2022 passed with 27,023,546 for, 73,833 against, 6,030 abstentions.
Broker non-votes totaled 3,142,984 on director election.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.